GPC2
Glypican-2
Also known as: cerebroglycan, DKFZp547M109, FLJ38962, GPC2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N158
- Gene
- GPC2
- Ensembl
- ENSG00000213420
- Chromosome
- 7
- Canonical length
- 579 aa
- Protein class
- Predicted intracellular proteins
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
Predicted to be involved in several processes, including positive regulation of neuron projection development; regulation of protein localization to membrane; and smoothened signaling pathway. Located in endoplasmic reticulum. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
579 residues, UniProt reviewed canonical sequence.
>Q8N158|GPC2
1 MSALRPLLLL LLPLCPGPGP GPGSEAKVTR SCAETRQVLG ARGYSLNLIP PALISGEHLR
61 VCPQEYTCCS SETEQRLIRE TEATFRGLVE DSGSFLVHTL AARHRKFDEF FLEMLSVAQH
121 SLTQLFSHSY GRLYAQHALI FNGLFSRLRD FYGESGEGLD DTLADFWAQL LERVFPLLHP
181 QYSFPPDYLL CLSRLASSTD GSLQPFGDSP RRLRLQITRT LVAARAFVQG LETGRNVVSE
241 ALKVPVSEGC SQALMRLIGC PLCRGVPSLM PCQGFCLNVV RGCLSSRGLE PDWGNYLDGL
301 LILADKLQGP FSFELTAESI GVKISEGLMY LQENSAKVSA QVFQECGPPD PVPARNRRAP
361 PPREEAGRLW SMVTEEERPT TAAGTNLHRL VWELRERLAR MRGFWARLSL TVCGDSRMAA
421 DASLEAAPCW TGAGRGRYLP PVVGGSPAEQ VNNPELKVDA SGPDVPTRRR RLQLRAATAR
481 MKTAALGHDL DGQDADEDAS GSGGGQQYAD DWMAGAVAPP ARPPRPPYPP RRDGSGGKGG
541 GGSARYNQGR SRSGGASIGF HTQTILILSL SALALLGPRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GPC2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- testis: 11 nTPM
- skin: 5.5 nTPM
- thymus: 4.8 nTPM
- amygdala: 2.2 nTPM
- spinal cord: 2.1 nTPM
- hippocampal formation: 2 nTPM
Single-cell type
- early spermatids: 42 nCPM
- oligodendrocyte progenitor cells: 18 nCPM
- late primary spermatocytes: 14 nCPM
- early primary spermatocytes: 11 nCPM
- thymocytes: 9.3 nCPM
- differentiating spermatogonia: 8.6 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- white matter: 2.2 nTPM
- medulla oblongata: 1.6 nTPM
- spinal cord: 1.5 nTPM
- cerebral cortex: 1.4 nTPM
- hippocampal formation: 1.4 nTPM
- amygdala: 1.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0.03
- gnomAD missense Z
- 1.01
- DepMap mean gene effect
- -0.19
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell migration
- neuron differentiation
- positive regulation of neuron projection development
- regulation of protein localization to membrane
- regulation of signal transduction
- smoothened signaling pathway
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GPC2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GPC2 as an antibody target. Whether an autoantibody or antibody against GPC2 could matter depends on whether native GPC2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GPC2 is annotated at the cell surface, where native GPC2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GPC2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...